Cyted Health

Cyted Health

Private
CambridgeHealthcare & Life Scienceshttps://cytedhealth.com

Last Round

Series B

Aug 30, 2025

Total Funding Raised

$22.59M

Company Overview

Cyted Health is a biotechnology company that provides a non-endoscopic diagnostic platform to enable the early detection of gastrointestinal diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Medical AI, Healthcare Analytics, Precision Medicine

Business Model

B2G

Customer Profile

Services & Consulting, Government Contracts, Hardware Sales

AI Layer

Application

Keywords

Cytospongeesophageal cancer detectionearly cancer detectionBarrett's Esophagus detectionnon-endoscopic testminimally-invasive diagnosticsmolecular diagnosticsAI pathologygastrointestinal diagnosticspill on a string testendoscopy alternativedigital pathologyswallowable capsule testdiagnostic serviceEndoSign®medical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cyted Health Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cyted Health Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BAug 30, 2025
GrantFeb 19, 2025
Series AMay 17, 2023
GrantApr 28, 2023
GrantFeb 1, 2020
VC Round
Feb 1, 2020

Key People

Founding team and executive leadership

Marcel Gehrung

CEO Co-Founder

Founding Team

Neha Goel

Chief Operating Officer

Executive Team

Cyted Health Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 25, 2026

    US molecular diagnostic test in final validation and early commercialization.

  • Apr 25, 2026

    Diagnostic solutions integrated into NHS pathways across UK sites.

Cyted Health Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cyted Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cyted Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range67
Year Founded2018
Last FundingAug 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.